BioNTech SE (BNTX) Form 10-Q Quarterly Reports
BioNTech SE (BNTX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BNTX
CIK: 1776985
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: 2M
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
EY GmbH & Co. KG Wirtschaftspruefungsgesellschaft
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerAndreas Weigel
Audit LocationCologne, Germany
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-13 | 2026-10-13 | 6-K | 0001776985-26-000067 | View SEC Doc Filr Page |
| 4 | 2026-10-09 | 2026-10-08 | FORM 4 | 0002123975-26-000035 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-07 | FORM 4 | 0002123975-26-000033 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-05 | FORM 4 | 0002123975-26-000031 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | FORM 4 | 0002123975-26-000029 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-29 | FORM 4 | 0002123975-26-000027 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-25 | FORM 4 | 0002123975-26-000025 | View SEC Doc Filr Page |
| 4 | 2026-09-24 | 2026-09-23 | FORM 4 | 0002123975-26-000023 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-21 | FORM 4 | 0002123975-26-000021 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-17 | FORM 4 | 0002123975-26-000019 | View SEC Doc Filr Page |
| 6-K | 2026-09-18 | 2026-09-18 | 6-K | 0001776985-26-000065 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-15 | FORM 4 | 0002123975-26-000017 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-11 | FORM 4 | 0002123975-26-000015 | View SEC Doc Filr Page |
| 6-K | 2026-09-14 | 2026-09-14 | 6-K | 0001776985-26-000063 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-10 | FORM 4 | 0002123975-26-000013 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | FORM 4 | 0002123975-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-03 | FORM 4 | 0002123975-26-000008 | View SEC Doc Filr Page |
| 144 | 2026-09-03 | — | 144 Filing | 0002085929-26-000012 | View SEC Doc Filr Page |
| 6-K | 2026-08-28 | 2026-08-28 | 6-K | 0001776985-26-000061 | View SEC Doc Filr Page |
| 6-K | 2026-08-27 | 2026-08-27 | 6-K | 0001776985-26-000059 | View SEC Doc Filr Page |
| 6-K | 2026-08-20 | 2026-08-20 | 6-K | 0001776985-26-000057 | View SEC Doc Filr Page |
| 6-K | 2026-08-04 | 2026-06-30 | 6-K | 0001776985-26-000055 | View SEC Doc Filr Page |
| 6-K | 2026-08-04 | 2026-08-04 | 6-K | 0001776985-26-000054 | View SEC Doc Filr Page |
| 6-K | 2026-08-03 | 2026-08-03 | 6-K | 0001776985-26-000051 | View SEC Doc Filr Page |
| 20-F/A | 2026-07-30 | 2025-12-31 | 20-F/A | 0001776985-26-000049 | View SEC Doc Filr Page |